HIGHLIGHTS
- who: Chunxia Su and Shi-Yong Sun from the Maastricht University Medical Centre, Atlanta, GA, United States have published the Article: Editorial: Challenges and opportunities of TKIs in the treatment of NSCLC patients with uncommon mutations, in the Journal: (JOURNAL) of 26/07/2022
- how: The results showed that RET-TKI remained the best choice for a better response rate and PFS.
- future: The authors thank all the authors for their inspiring contributions to this Research Topic and hope that these papers will provide the readers with a deep understanding of the current . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.